Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism. NICE technology appraisal guidance 261
National Institute for Health and Care Excellence (NICE)
Record ID 32018011203
English
Details
Project Status:
Completed
URL for project:
https://www.nice.org.uk/guidance/ta261
Year Published:
2012
URL for published report:
https://www.nice.org.uk/guidance/ta261
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
England
MeSH Terms
- Embolism and Thrombosis
- Venous Thrombosis
- Upper Extremity Deep Vein Thrombosis
- Pulmonary Embolism
- Rivaroxaban
- Anticoagulants
- Factor Xa Inhibitors
Contact
Organisation Name:
National Institute for Health and Care Excellence
Contact Address:
Level 1A, City Tower, Piccadilly Plaza, Manchester, M1 4BT
Contact Name:
nice@nice.nhs.uk
Contact Email:
nice@nice.nhs.uk
Copyright:
National Institute for Health and Care Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.